Lepu Biopharma Co., Ltd. (HKG:2157)
Hong Kong · Delayed Price · Currency is HKD 4.235
+0.150 (3.67%)
Aug 20, 2026, 4:09 PM HKT
Lepu Biopharma Market Cap
Lepu Biopharma has a market cap or net worth of 7.64 billion as of August 20, 2026. Its market cap has decreased by -55.93% in one year.
Market Cap
7.64B
Enterprise Value
8.06B
Revenue
1.14B
Ranking
n/a
PE Ratio
20.74
Stock Price
4.24
ChartMarket Cap Chart
Since February 23, 2022, Lepu Biopharma's market cap has decreased from 11.84B to 7.64B, a decrease of -35.47%. That is a compound annual growth rate of -9.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 7.64B | -14.79% |
| Dec 31, 2025 | 8.97B | 100.10% |
| Dec 31, 2024 | 4.48B | -35.85% |
| Dec 29, 2023 | 6.99B | -42.72% |
| Dec 30, 2022 | 12.20B | 3.00% |
| Feb 23, 2022 | 11.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascletis Pharma | 10.38B |
| Shaanxi Micot Pharmaceutical Technology | 10.15B |
| TenNor Therapeutics (Suzhou) | 9.31B |
| CARsgen Therapeutics Holdings | 8.86B |
| Suzhou Ribo Life Science | 8.84B |
| LongBio Pharma (Suzhou) | 8.51B |
| Everest Medicines | 8.36B |
| CStone Pharmaceuticals | 8.18B |